Zentalis Pharmaceuticals(ZNTL)
SAN DIEGO, CAPharmaceutical
Focus: Zentalis Pharmaceuticals is a public-stage biopharmaceutical company focused on small-molecule oncology therapeutics, headquartered in San Diego. The company is advancing a pipeline of early-stage cancer programs with a therapeutic focus on neurology and solid tumors.
Profile data last refreshed 3h ago · AI intelligence enriched Yesterday
Funding Stage
PUBLIC
Open Jobs
6+4 this month
Stable — net +4 jobs in 30d
4 added, 0 removed. Backfill posture.
Should You Work at Zentalis Pharmaceuticals?
AI assessmentZentalis offers high-impact early oncology work with recent clinical momentum, but pre-revenue status and cash depletion trajectory present significant execution and financial risk.
Why Work Here
- Active pipeline with 15 ongoing trials across oncology indications including ovarian cancer, colorectal cancer, and AML—offering exposure to diverse cancer biology and translational science
Data completeness
5/9 — Partial
Company HealthStrong
Pipeline
Early-stage
15 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Revenue
$0K
Pipeline & Clinical Trials
ZN-d5
Healthy VolunteersClinical Trials (1)
NCT04854174A Food Effect Study of ZN-d5 in Healthy Female Volunteers
Phase 1Help build intelligence for Zentalis Pharmaceuticals
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.